Category Press Releases

Enveric Biosciences

Sensei Biotherapeutics Grants Stock Options to 17 New Employees, Including COO

Strategic Move to Attract and Retain Talent in the Biotech Sector What does it take to attract top talent in the highly competitive biotech industry? Sensei Biotherapeutics, Inc. a clinical-stage biotechnology company focused on developing next-generation therapeutics for cancer patients,…

Read MoreSensei Biotherapeutics Grants Stock Options to 17 New Employees, Including COO
Pearl

Pearl Dental AI Solutions Partner with DECA Dental Group to Enhance Patient Care

DECA Dental Group Adopts Pearl’s AI to Improve Clinical Outcomes and Patient Engagement In the rapidly evolving landscape of dental technology, the integration of artificial intelligence (AI) is becoming a game-changer. Pearl, the global leader in dental AI solutions, has announced…

Read MorePearl Dental AI Solutions Partner with DECA Dental Group to Enhance Patient Care
BreezeBio

Verdiva Bio Completes Enrollment for Phase 2b EVOLVE-2 Study of VRB-101

Verdiva Bio Advances Obesity Therapy with Once-Weekly Oral GLP-1 Peptide Analog Is the pharmaceutical industry on the brink of a breakthrough in obesity treatment? Verdiva Bio Limited a clinical-stage biopharmaceutical company focused on developing innovative therapies for obesity and cardiometabolic disorders, has…

Read MoreVerdiva Bio Completes Enrollment for Phase 2b EVOLVE-2 Study of VRB-101
NorthX Biologics

NorthX Biologics and Demeetra Collaborate to Accelerate Biologics Development

Strategic Partnership Combines Best-in-Class Cell Line Development and GMP Manufacturing Why do biotech companies often face long development cycles and costly delays? NorthX Biologics and Demeetra have formed a strategic collaboration to address these challenges. NorthX Biologics, a leading contract…

Read MoreNorthX Biologics and Demeetra Collaborate to Accelerate Biologics Development
Guardant Health

Pelage Pharmaceuticals Strengthens Leadership and Board with Strategic Appointments

Pelage Pharmaceuticals Appoints New Board Member and Promotes Key Executives In the competitive landscape of regenerative medicine, where innovative solutions for hair loss are increasingly in demand, Pelage Pharmaceuticals is making strategic moves to solidify its position. The company, a…

Read MorePelage Pharmaceuticals Strengthens Leadership and Board with Strategic Appointments
Bristol Myers Squibb

Bristol Myers Squibb Advances Alpha-Thalassemia Treatment With Reblozyl

Positive Top-Line Results for Reblozyl in Alpha-Thalassemia Study Is the treatment landscape for alpha-thalassemia about to change? Bristol Myers Squibb has announced positive top-line results from an ongoing, ex-US, Phase 2 registrational study evaluating Reblozyl® (luspatercept-aamt) versus placebo for anemia…

Read MoreBristol Myers Squibb Advances Alpha-Thalassemia Treatment With Reblozyl
Gilead

Gilead Sciences Acquires Arcellx for $7.8 Billion to Advance Cancer Immunotherapies

Gilead Sciences Seals $7.8 Billion Deal for Arcellx to Boost CAR T-Cell Therapy In the rapidly evolving landscape of cancer immunotherapies, where breakthroughs are crucial for patient outcomes, Gilead Sciences, Inc. has made a significant move. The biopharmaceutical giant has…

Read MoreGilead Sciences Acquires Arcellx for $7.8 Billion to Advance Cancer Immunotherapies